Definitive Contract HHSF223201610073C
- Not listed
- The U.S. Food and Drug Administration (FDA) awarded a $159,835 firm fixed price purchase order to the University of Maryland, Baltimore to continue providing high quality infectious disease genomic nucleic acid for the FDA's ARGOS database. This sole source contract, previously held by the University of Maryland since 2015, will support the FDA's need for reference grade microbial sequences through September 2020. The University System of Maryland serves as the parent organization for the...
- The University of Maryland, Baltimore has been awarded a federal contract by the Food and Drug Administration to generate highly curated whole genome sequences for bacterial pathogens from the FDA-CDC Antimicrobial Resistance Isolate Bank. The $199,985.00 definitive, firm fixed-price contract does not have a set-aside designation. The University of Maryland, Baltimore is the prime contractor and is a major public research university that frequently receives federal funding through contracts...
- This federal contract award was issued by the Southeast Area of a civilian federal agency to the University of Maryland, Baltimore (UMB) as the prime contractor. The $24,062.50 firm fixed-price purchase order is for other functions related to 7 Illumina HiSeq4000 sequencing lanes, including quality control assessment, data processing, and delivery of sequencing data for 84 bee genomic DNA samples. UMB, as a state-controlled institution of higher learning, has extensive expertise in biomedical...
- This federal contract award, with a ceiling value of $10,500.00, was issued by the Southeast Area of the U.S. government to the University of Maryland, Baltimore (UMB) as the prime contractor. The contract is for other functions related to 84 high-throughput paired-end Illumina libraries, including quality control assessment, Illumina paired-end library preparation, data quality control, and delivery of the resulting data sets for 84 bee genomic DNA samples. The contract is a firm fixed-price...
- This is a $29,057,109.85 definitive federal contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to the University of Maryland, Baltimore (UMB) for biomedical research and development. The contract has no set-aside designation. UMB, a major public research university, is the prime contractor and frequently receives federal contracts and grants for its expertise in areas such as medicine, nursing,...
- The University of Maryland, Baltimore (UMB) has been awarded a $7,594.08 firm fixed price purchase order contract by the National Institute of Allergy and Infectious Diseases (NIAID) for micro-satellite testing and pyro-sequencing services. UMB, a major public research university, frequently receives federal contracts and grants to support its biomedical and clinical research activities. This contract, which is not set aside, is likely part of a larger research initiative at NIAID, the...
- The Food and Drug Administration awarded a $288,274 firm fixed-price definitive contract to the University of Maryland Baltimore (UMB) on August 27, 2025, with an ultimate completion date of September 29, 2027. This contract supports the Combating Antimicrobial Resistance Bacteria (CARB) Research Program, which identifies and funds research areas where regulatory science can advance new antibacterial drug development by creating innovative drug development tools and standards. The contract is...
- This is a $5,150.00 firm fixed-price purchase order awarded by the Department of Veterans Affairs (VA) to the University of Maryland, Baltimore (UMB) to conduct genome sequencing of 12 pooled bee samples. The work is being performed at UMB's Baltimore campus and has a completion date of November 30, 2019. UMB is the prime contractor on this award, which was not set aside for any socioeconomic category. The award is related to UMB's $6 million Blanket Purchase Agreement with the VA to provide...
- This federal contract award was issued by the Centers for Disease Control and Prevention (CDC) to the University of Maryland, Baltimore (UMB) to provide AR Sentinel Site Surveillance for AR Organisms. The $99,990.00 Firm Fixed Price Delivery Order was placed under the CDC's Safety and Healthcare Epidemiology Prevention Research Development (SHEPheRD) Indefinite Delivery Indefinite Quantity (IDIQ) contract. The work is to be performed in Baltimore, MD. UMB serves as the prime contractor on this...
- This is a $61,418 firm fixed price contract awarded by the Department of Health and Human Services (HHS) Food and Drug Administration (FDA) to the University of Maryland, Baltimore (UMB) on July 29, 2020. The contract is for the manufacture of an in vitro component to evaluate generic and new animal drug formulations that are not systemically absorbed. The contract has no set-aside designation and is scheduled for completion on June 30, 2023. UMB is a medical research university that has...
This federal contract award, valued at $302,375.01, was issued by the Food and Drug Administration (FDA) to the University of Maryland, Baltimore (UMB) to conduct "Genome Sequencing of Mosquito Borne Viral Pathogens in Support of FDA ARGOS." The award is a definitive, firm fixed-price contract with no set-aside designation. UMB, the prime contractor, is a major public research university that frequently collaborates with federal agencies on biomedical research, healthcare services, and educational initiatives. The University System of Maryland is the parent organization of UMB. This contract supports the FDA's ARGOS program, which focuses on genome sequencing of mosquito-borne viral pathogens. Through this award, UMB will provide the necessary services and expertise to advance the FDA's efforts in this critical research area.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Food and Drug Administration Broad Agency Announcement for the Advanced Research and Development of Regulatory Science | FDABAA-16-00122 | Department of Health and Human Services Food and Drug Administration | Award Notice 1/1 | 2/23/16, 9:54 AM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00004 | Close Out | ($908) | 1/19/22 | |
| 3 | Other Administrative Action | $0 | 4/11/19 | |
| 2 | Other Administrative Action | $0 | 4/4/18 | |
| 1 | Other Administrative Action | $0 | 1/12/17 | |
| Not listed | Not listed | $303.3k | 8/17/16 |